Results 21 to 30 of about 1,213 (179)

Hemolytic disease of fetus and newborn due to maternal AlloAnti-S antibody

open access: yesAsian Journal of Transfusion Science
Hemolytic disease of foetus and newborn (HDFN) is a disease characterized by the destruction of fetal red cells by the maternal antibodies which occurs due to allo immunization in the mother by feto-maternal blood group incompatibility.The antibodies ...
Suresh Kumar Iyyapan   +3 more
doaj   +2 more sources

Maternal-fetal isoimmunization – a risk for the development of hemolytic disease of the newborn [PDF]

open access: yesPharmacia
Hemolytic disease of the newborn is a condition caused by maternal alloimmunization against fetal red blood cell antigens. Transplacental hemorrhage, for example, can provoke an immune response in the mother.
Maria Hristova Savcheva   +18 more
doaj   +5 more sources

Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children.

open access: yesPLoS ONE, 2020
In the mid-20th century, Hemolytic Disease of the Fetus and Newborn, caused by maternal alloimmunization to the Rh(D) blood group antigen expressed by fetal red blood cells (i.e., "Rh disease"), was a major cause of fetal and neonatal morbidity and ...
Valeria Pegoraro   +6 more
doaj   +2 more sources

Hemolytic disease of the fetus and newborn: A review of pathophysiology, diagnosis, and management

open access: yesBest Practice & Research Clinical Obstetrics & Gynaecology
Hemolytic Disease of the Fetus and Newborn (HDFN) results from maternal alloantibodies attacking fetal red blood cells, leading to fetal anemia and potentially severe complications such as hydrops fetalis. Effective management relies on early detection through maternal antibody screening, fetal antigen testing, and close monitoring of fetal anemia.
Hajra Malik   +2 more
openaire   +3 more sources

Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis.

open access: yesPLoS ONE, 2020
BackgroundSeveral anti-D immunoglobulin strategies exist for preventing Rh hemolytic disease of the fetus and newborn. This study systematically assessed the clinical value of those therapeutic strategies.MethodsThe Web of Science, PubMed, EMBASE, China ...
Xiaohui Xie   +4 more
doaj   +2 more sources

Five Pathogenetic Classifications for Alloimmune Hemolytic Disease of the Fetus And Newborn

open access: yesTransfusion Medicine Reviews
Maternal alloantibody-induced hemolytic disease of the fetus and newborn (HDFN) remains a significant concern worldwide. Alloimmune HDFN can be pathogenetically named by the specific alloantibodies involved. Moreover, four mechanistic pathway types are generally recognized in clinical practice: classical or extravascular hemolysis; immune-pressure ...
Hitoshi Ohto   +2 more
openaire   +3 more sources

Hemolytic disease of the fetus and newborn: managing the mother, fetus, and newborn [PDF]

open access: yesHematology, 2015
Abstract Hemolytic disease of the fetus and newborn (HDFN) affects 3/100 000 to 80/100 000 patients per year. It is due to maternal blood group antibodies that cause fetal red cell destruction and in some cases, marrow suppression. This process leads to fetal anemia, and in severe cases can progress to edema, ascites, heart failure ...
Meghan, Delaney, Dana C, Matthews
openaire   +2 more sources

In vitro assessment of recombinant, mutant immunoglobulin G anti-D devoid of hemolytic activity for treatment of ongoing hemolytic disease of the fetus and newborn [PDF]

open access: yes, 2008
A specific treatment for ongoing hemolytic disease of the fetus and newborn (HDFN) due to anti-D would be very attractive. One approach could be administration to the mother of nonhemolytic anti-D, which by crossing the placenta can block the binding of ...
Nielsen, Leif K   +6 more
core   +1 more source

Are fetal bilirubin levels associated with the need for neonatal exchange transfusions in hemolytic disease of the fetus and newborn? [PDF]

open access: yes, 2021
BACKGROUND: Fetal bilirubin is routinely measured at our center when taking a pretransfusion blood sample at intrauterine transfusions in hemolytic disease of the fetus and newborn.
Ree, I.M.C.   +13 more
core   +1 more source

Blood immunological analysis of hemolytic disease of the fetus and newborn caused by Rh deletion type D--

open access: yesZhongguo shuxue zazhi, 2023
Objective To analyze the causes of a case of hemolytic disease of the fetus and newborn (HDFN),and investigate the genetic background of maternal Rh deletion D--formation.
Yiman ZHAO   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy